Retention of golimumab treatment following discontinuation of non‐TNF inhibitors in patients with inflammatory rheumatic diseases: An analysis of the Spanish BIOBADASER registry - Pombo‐Suárez, Manuel; Sanchez‐Piedra, Carlos; Ruiz‐Montesino, Dolores; Diaz‐Torne, Cesar; Jovaní, Vega; Cea‐Calvo, Luis; Castrejón, Isabel (Musculoskeletal care, 2022)
Keywords: axial spondylarthritis; golimumab; medication retention rate; Monoclonal antibodies; psoriatic arthritis; rheumatoid arthritis; TNF inhibitors; axial spondylarthritis; medication retention rate; psoriatic arthritis; rheumatoid arthritis; golimumab